H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, trend analysis, applicable previous investigation(s), sample (if available), and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a hair in the sealed package was confirmed and the cause appeared to be supplier-related.The product returned for evaluation was one 20ga x 0.75¿ safestep safety infusion set.The sample was received in its original sealed packaging.The seal was intact and unremarkable.A hair-like fiber was visible within the packaging, apparently adhered to the luer adapter.The sealed state of the device packaging indicated that the fiber had been deposited on the device prior to packaging sealing, during device manufacture.The device is a supplied component and the supplier has been notified of this event.
|